anti-platelet therapy
Showing 1 - 25 of >10,000
Coronary Artery Disease Trial in Seoul (Clopidogrel monotherapy, Tailored anti-platelet therapy)
Not yet recruiting
- Coronary Artery Disease
- Clopidogrel monotherapy
- Tailored anti-platelet therapy
-
Seoul, Korea, Republic ofSeverance Hospital
Jul 3, 2023
Head Neck Cancer Trial in Charleston (Pembrolizumab, Clopidogrel, acetylsalicylic acid)
Recruiting
- Head and Neck Cancer
- Pembrolizumab
- +2 more
-
Charleston, South CarolinaMedical University of South Carolina
Dec 22, 2022
COPD, Emphysema, Emphysema or COPD Trial (dual anti-platelet therapy, Placebo)
Not yet recruiting
- COPD
- +2 more
- dual anti-platelet therapy
- Placebo
- (no location specified)
Oct 9, 2022
Dutch Adult Cardiac Surgery Population, and Effect on
Not yet recruiting
- P2Y12 Receptor Inhibitor
- +2 more
- TRACK-TCT
-
Enschede, Overijssel, NetherlandsThoraxcentrum Twente
Oct 12, 2022
Percutaneous Intervention Trial in Shatin (Orsiro Mission, Resolute Onyx)
Recruiting
- Percutaneous Intervention
- Orsiro Mission
- Resolute Onyx
-
Shatin, Hong KongThe Chinese University of Hong Kong
Sep 19, 2022
Ischemic Stroke, Vertebral Artery Stenosis Trial in Beijing (Drug-eluting stenting plus aspirin and clopidogrel or ticagrelor,
Not yet recruiting
- Ischemic Stroke
- Vertebral Artery Stenosis
- Drug-eluting stenting plus aspirin and clopidogrel or ticagrelor
- +2 more
-
Beijing, ChinaXuanwu Hospital, Capital Medical University.
Jun 1, 2023
Coronary Artery Disease, Atherosclerosis, Stent Placement Trial in Scottsdale, Boston, New York (Dual Antiplatelet (DAPT)
Active, not recruiting
- Coronary Artery Disease
- +2 more
- Dual Antiplatelet (DAPT) Therapy
- The Synergy® stent
-
Scottsdale, Arizona
- +2 more
Feb 15, 2022
Cardiovascular Diseases, Acute Coronary Syndrome Trial in Newark, Baltimore, Danville (clopidogrel, prasugrel)
Terminated
- Cardiovascular Diseases
- Acute Coronary Syndrome
-
Newark, Delaware
- +4 more
Mar 7, 2022
Reduced Anti-coagulation/Anti-platelet Therapy in HeartMate II
Completed
- Anticoagulation
- Left Ventricular Assist Device
-
San Diego, California
- +17 more
Jun 23, 2022
Platelet Activation Testing Before/After Anti-platelet Therapy, Healthy Trial in Boston (Aspirin, Clopidogrel)
Recruiting
- Platelet Activation Testing Before/After Anti-platelet Therapy
- Healthy
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Mar 31, 2022
Chronic Kidney Diseases Trial in Seoul (dual anti-platelet therapy at least 6 months, dual anti-platelet therapy 3months or
Recruiting
- Chronic Kidney Diseases
- dual anti-platelet therapy at least 6 months
- dual anti-platelet therapy 3months or less
-
Seoul, Korea, Republic ofDivision of Cardiology, Yonsei Cardiovascular Hospital, Yonsei U
Jul 28, 2021
Myocardial Infarction, Acute, Coronary Artery Disease Trial in Worldwide (Shortened DAPT followed by P2Y12 inhibitor monotherapy
Recruiting
- Myocardial Infarction, Acute
- Coronary Artery Disease
- Shortened DAPT followed by P2Y12 inhibitor monotherapy (cessation of aspirin)
- Standard DAPT
-
St Pölten, Austria
- +37 more
Dec 7, 2022
Patent Foramen Ovale, Migraine Trial (Aspirin 100mg, Metoprolol 25 Mg Oral Tablet, Clopidogrel 75mg)
Recruiting
- Patent Foramen Ovale
- Migraine
- Aspirin 100mg
- +3 more
-
Beijing, Beijing, ChinaFuwai Hospital
Jan 9, 2023
Ticagrelor in Elderly Patients Undergoing Percutaneous Coronary
Completed
- Platelet Aggregation Inhibitors
- +3 more
-
Dalian, ChinaThe First Affiliated Hospital of Dalian Medical University
Aug 5, 2021
Coronary Artery Disease Trial in Jacksonville (Ticagrelor 60mg, Clopidogrel)
Recruiting
- Coronary Artery Disease
- Ticagrelor 60mg
- Clopidogrel
-
Jacksonville, FloridaUniversity of Florida
Jul 6, 2022
Acute Coronary Syndrome, Coronary Artery Disease Trial in Edinburgh (3 months dual anti-platelet therapy, 12 months dual
Recruiting
- Acute Coronary Syndrome
- Coronary Artery Disease
- 3 months dual anti-platelet therapy
- 12 months dual anti-platelet therapy
-
Edinburgh, United KingdomEdinburgh Royal Infirmary
Nov 10, 2020
Dual Anti-platelet Therapy Trial in Rome
Completed
- Dual Anti-platelet Therapy
-
Rome, Please Select, ItalyUniversity Sapienza
Apr 13, 2021
Atrial Fibrillation Trial in Seoul (NOAC monotherapy, Dual therapy with apixaban and clopidogrel)
Recruiting
- Atrial Fibrillation
- NOAC monotherapy
- Dual therapy with apixaban and clopidogrel
-
Seoul, Korea, Republic ofSeverance Cardiovascular Hospital, Yonsei University Health Syst
Sep 10, 2021
Drug-Eluting Stents, Percutaneous Coronary Intervention Trial in Shanghai (3 months DAPT, 12 months DAPT)
Unknown status
- Drug-Eluting Stents
- Percutaneous Coronary Intervention
- 3 months DAPT
- 12 months DAPT
-
Shanghai, ChinaShanghai Zhongshan Hospital
Sep 8, 2020
Anti-coagulation and Anti-Platelet Therapies for Intracranial
Not yet recruiting
- Stroke
- Intracranial Atherosclerotic Stenosis (ICAS)
- MRI
- (no location specified)
Jun 7, 2023
Pyoderma Gangrenosum Trial (Platelet rich plasma therapy)
Not yet recruiting
- Pyoderma Gangrenosum
- Platelet rich plasma therapy
- (no location specified)
Aug 2, 2023
Ischemic Stroke Trial in Daejeon (Aspirin, Clopidogrel)
Completed
- Ischemic Stroke
- Aspirin, Clopidogrel
-
Daejeon, Korea, Republic ofChungnam National University Hospital
Oct 10, 2022
Periodontal Pocket Trial in Bangalore (C-PRF)
Completed
- Periodontal Pocket
- C-PRF
-
Bangalore, Karnataka, IndiaKrishnadevaraya college of dental sciences
Jul 14, 2023